Prognostic Factors According to the Treatment Schedule in Malignant Pleural Mesothelioma

AK, GÜNTÜLÜ; Metintas, SELMA; METİNTAŞ, MUZAFFER; YILDIRIM, HÜSEYİN; Erginel, MEHMET; KURT, EMEL; ALATAŞ, FÜSUN; Cadirci, Omer

doi:10.1097/jto.0b013e3181ba2033

Prognostic Factors According to the Treatment Schedule in Malignant Pleural Mesothelioma

Atıf İçin Kopyala

AK G., Metintas S., METİNTAŞ M., YILDIRIM H., Erginel S., KURT E., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.4, sa.11, ss.1425-1430, 2009 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 4 Sayı: 11
Basım Tarihi: 2009
Doi Numarası: 10.1097/jto.0b013e3181ba2033
Dergi Adı: JOURNAL OF THORACIC ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1425-1430
Anahtar Kelimeler: Malignant pleural mesothelioma, Prognostic factors, Treatment schedule, EUROPEAN-ORGANIZATION, LUNG-CANCER, PHASE-III, SURVIVAL, CHEMOTHERAPY, OSTEOPONTIN, VALIDATION, EXPERIENCE, CISPLATIN
Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objectives: In this study, we aimed to investigate the factors affecting the survival of patients with malignant pleural mesothelioma (MPM) according to their treatment schedules, including those treated with best supportive care, chemotherapy, and multimodality therapy.